Skip to main content Accessibility help
×
Home
  • Print publication year: 2013
  • Online publication date: May 2013

14 - Mood disorders in the context of borderline personality disorder

from Section 2 - Medical management

Summary

Pathologic rejection sensitivity is the most common feature of depression with atypical features. While monoamine oxidase inhibitors (MAOI) studies suggested that MAOIs might be useful first-line agents in treatment of depression with atypical features, dietary restrictions, high rates of side effects, such as weight gain and sexual dysfunction, and significant drug-drug interactions make MAOIs less attractive in practice. Hence, the advent of the more user-friendly selective serotonin reuptake inhibitors (SSRIs) had significant appeal. The literature is clear that phenelzine is a superior choice over imipramine for the treatment of depression with atypical features, particularly if onset is early and the course is very chronic. Prior to starting an MAOI, the patient must be educated about the content of and rationale for the tyramine-free diet and dangerous medications, such as SRIs and meperidine. The selegiline patch has the side effects of other MAOIs.

References

Abela, J.R., Payne, A.V., and Moussaly, N. (2003). Cognitive vulnerability to depression in individuals with borderline personality disorder. Journal of Personality Disorders, 17, 319–329.
Akiskal, H.S. (2004). Demystifying borderline personality: critique of the concept and unorthodox reflections on its natural kinship with the bipolar spectrum. Acta Psychiatrica Scandinavica, 110, 401–407.
Akiskal, H.S., Chen, S.E., Davis, G.C.et al. (1985). Borderline: An adjective in search of a noun. Journal of Clinical Psychiatry, 46, 7.
APA (2010). Practice Guidelines for the Treatment of Patients with Bipolar Disorder, Second Edition. Arlington, VA: American Psychiatric Association.
Bassett, D. (2012). Borderline personality disorder and bipolar affective disorder. Spectra or spectre? A review. Australian and New Zealand Journal of Psychiatry, 46, 327–339.
Beck, A.T. and Steer, R.A. (1993). Beck Depression Inventory Manual. San Antonio, TX: Psychological Corporation.
Benazzi, F. (2008). A relationship between bipolar II disorder and borderline personality disorder? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32, 1022–1029.
Binks, C.A., Fenton, M., McCarthy, L.et al. (2006). Pharmacological interventions for people with borderline personality disorder. Cochrane Database of Systematic Reviews, 25, CD005653.
Bowden, C. and Maier, W. (2003). Bipolar disorder and personality disorder. European Psychiatry, 18, 3.
Brodsky, B.S., Groves, B.A., Oquendo, M.A., Mann, J.J., and Stanley, B. (2006). Suicide risk and environmental stressors: Comparing depressed attempters with and without borderline personality disorder. Suicide and Life Threatening Behavior, 36, 313–322.
Calabrese, J.R. (2005). Clinical highlights in bipolar depression: Focus on atypical antipsychotics. Journal of Clinical Psychiatry, 66, 26.
Colom, F., Vieta, E., Sanchez-Moreno, J.et al. (2004). Psychoeducation in bipolar patients with comorbid personality disorders. Bipolar Disorders, 6, 4.
Corbitt, E. M., Malone, K. M., Haas, G.L., and Mann, J.J. (1996). Suicidal behavior in patients with major depression and comorbid personality disorders. Journal of Affective Disorders, 39, 61–72.
Davis, G.C. and Akiskal, H.S. (1986). Descriptive, biological, and theoretical aspects of borderline personality disorder. Hospital and Community Psychiatry, 37, 685–692.
Deltito, J., Martin, L., Riefkohl, J.et al. (2001). Do patients with borderline personality disorder belong to the bipolar spectrum? Journal of Affective Disorders, 67, 221–228.
Donegan, N.H., Sanislow, C.A., Blumberg, H.P.et al. (2003). Amygdala hyperreactivity in borderline personality disorder: Implications for emotional dysregulation. Biological Psychiatry, 54, 1284–1293.
Driessen, M., Herrmann, J., Stahl, K.et al. (2000). Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Archives of General Psychiatry, 57, 1115–1122.
Fertuck, E.A., Makhija, N., and Stanley, B. (2007). The nature of suicidality in borderline personality disorder. Primary Psychiatry, 14, 40–47.
Fertuck, E.A., Lenzenweger, M.F., Clarkin, J.F., Hoermann, S., and Stanley, B. (2006a). Executive neurocognition, memory systems, and borderline personality disorder. Clinical Psychology Review, 26(3), 346–375.
Fertuck, E.A., Marsano-Jozefowicz, S., Stanley, B.et al. (2006b). The impact of borderline personality disorder and anxiety on neuropsychological performance in major depression. Journal of Personality Disorders, 20, 55–70.
Feske, U., Mulsant, B.H., Pilkonis, P.A.et al. (2004). Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. American Journal of Psychiatry, 161, 2073–2080.
Feurino Iii, L. and Silk, K.R. (2011). State of the art in the pharmacologic treatment of borderline personality disorder. Current Psychiatry Reports, 13, 69–75.
Frankenburg, F.R. and Zanarini, M.C. (2002). Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: A double-blind placebo-controlled pilot study. Journal of Clinical Psychiatry, 63, 442–446.
Garno, J.L. (2005). Bipolar disorder with comorbid cluster B personality disorder features: Impact on suicidality. Journal of Clinical Psychiatry, 66, 339.
Goldstein, T.R., Axelson, D.A., Birmaher, B.O.R.I., and Brent, D.A. (2007). Dialectical behavior therapy for adolescents with bipolar disorder: A 1-year open trial. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 820–830.
Goodman, M., New, A., Triebwasser, J., Collins, K.A., and Siever, L. (2010). Phenotype, endophenotype, and genotype comparisons between borderline personality disorder and major depressive disorder. Journal of Personality Disorders, 24, 38–59.
Grant, B.F., Chou, P.S., Goldstein, R.B. (2008). Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: Results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 69, 533.
Grilo, C.M., Stout, R.L., Markowitz, J.C. (2010). Personality disorders predict relapse after remission from an episode of major depressive disorder: S 6-year prospective study. Journal of Clinical Psychiatry, 71, 1629–1635.
Grunhaus, L., King, D., Greden, J.F., and Flegel, P. (1985). Depression and panic in patients with borderline personality disorder. Biological Psychiatry, 20, 688–692.
Gunderson, J.G. and Phillips, K.A. (1991). A current view of the interface between borderline personality disorder and depression. American Journal of Psychiatry, 148, 967–975.
Gunderson, J.G., Morey, L.C., Stout, R.L.et al. (2004). Major depressive disorder and borderline personality disorder revisited: Longitudinal interactions. Journal of Clinical Psychiatry, 65, 1049–1056.
Gunderson, J.G., Weinberg, I., Daversa, M.T.et al. (2006). Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder. American Journal of Psychiatry, 163, 1173–1178.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
Hasin, D.S., Goodwin, R.D., Stinson, F.S., and Grant, B.F. (2005). Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Archives of General Psychiatry, 62, 1097–1106.
Henry, C., Mitropoulou, V., New, A.et al. (2001). Affective instability and impulsivity in borderline personality and bipolar II disorders: Similarities and differences. Journal of Psychiatric Research, 35, 5.
Herpertz, S.C. (2003). Emotional processing in personality disorder. Current Psychiatry Reports, 5, 23–27.
Herpertz, S.C., Dietrich, T.M., Wenning, B.et al. (2001). Evidence of abnormal amygdala functioning in borderline personality disorder: A functional MRI study. Biological Psychiatry, 50, 292–298.
Johnson, P.A., Hurley, R.A., Benkelfat, C., Herpertz, S.C., and Taber, K.H. (2003). Understanding emotion regulation in borderline personality disorder: Contributions of neuroimaging. Journal of Neuropsychiatry and Clinical Neuroscience, 15, 397–402.
Joyce, P.R., Mulder, R.T., Luty, S.E.et al. (2003). Borderline personality disorder in major depression: Symptomatology, temperament, character, differential drug response, and 6-month outcome. Comprehensive Psychiatry, 44, 35–43.
Kelly, T.M., Soloff, P.H., Lynch, K.G., Haas, G.L., and Mann, J.J. (2000). Recent life events, social adjustment, and suicide attempts in patients with major depression and borderline personality disorder. Journal of Personality Disorders, 14, 316–326.
Kernberg, O.F. (2001). The suicidal risk in severe personality disorders: Differential diagnosis and treatment. Journal of Personality Disorders, 15, 195–208; discussion 209–215.
King-Casas, B., Sharp, C., Lomax-Bream, L.et al. (2008). The rupture and repair of cooperation in borderline personality disorder. Science, 321, 806–810.
Koenigsberg, H.W., Fan, J., Ochsner, K.N.et al. (2007). Neural Correlates of Emotion Dysregulation in Borderline Personality Disorder. Paper presented at the American College of Neuropsychopharmacology.
Koenigsberg, H.W., Fan, J., Ochsner, K.N.et al. (2009). Neural correlates of the use of psychological distancing to regulate responses to negative social cues: A study of patients with borderline personality disorder. Biological Psychiatry, 66, 854–863.
Linehan, M.M. (1993). Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York, NY: Guilford.
Linehan, M.M., Armstrong, H.E., Suarez, A., Allmon, D., and Heard, H.L. (1991). Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48, 1060–1064.
Linehan, M.M., Comtois, K.A., Murray, A.M.et al. (2006). Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63, 757–766.
Links, P.S., Heslegrave, R.J., Mitton, J.E.et al. (1995). Borderline psychopathology and recurrences of clinical disorders. Journal of Nervous and Mental Disease, 183, 582–586.
Loranger, A.W., Oldham, J.M., and Tulis, E.H. (1982). Familial transmission of DSM-III borderline personality disorder. Archives of General Psychiatry, 39, 795–799.
MacKinnon, D.F. and Pies, R. (2006). Affective instability as rapid cycling: theoretical and clinical implications for borderline personality and bipolar spectrum disorders. Bipolar Disorders, 8, 1–14.
Magill, C.A. (2004). The boundary between borderline personality disorder and bipolar disorder: Current concepts and challenges. Canadian Journal of Psychiatry, 49, 551.
Minzenberg, M.J., Fan, J., New, A.S., Tang, C.Y., and Siever, L.J. (2007). Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: An event-related fMRI study. Psychiatry Research – Neuroimaging, 155, 231–243.
Morey, L.C., Shea, M.T., Markowitz, J.C.et al. (2010). State effects of major depression on the assessment of personality and personality disorder. American Journal of Psychiatry, 167, 528–535.
New, A.S., Triebwasser, J., and Charney, D.S. (2008). The case for shifting borderline personality disorder to Axis I. Biological Psychiatry, 64, 653–659.
Nierenberg, A.A., Alpert, J.E., Pava, J., Rosenbaum, J.F., and Fava, M. (1998). Course and treatment of atypical depression. Journal of Clinical Psychiatry, 59 Suppl 18, 5–9.
Oldham, J.M. (2006). Borderline personality disorder and suicidality. American Journal of Psychiatry, 163, 20–25.
Oquendo, M.A., A. Krunic, Parsey, R.V.et al. (2005). Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder. Neuropsychopharmacology, 30, 1163–1172.
Orbach, I., Mikulincer, M., Gilboa- Schechtman, E., and Sirota, P. (2003a). Mental pain and its relationship to suicidality and life meaning. Suicide and Life Threatening Behavior, 33, 231–241.
Orbach, I., Mikulincer, M., Sirota, P., and Gilboa-Schechtman, E. (2003b). Mental pain: A multidimensional operationalization and definition. Suicide and Life Threatening Behavior, 33, 219–230.
Paris, J. (2007). The nature of borderline personality disorder: multiple dimensions, multiple symptoms, but one category. Journal of Personality Disorders, 21, 457–473.
Paris, J., Gunderson, J., and Weinberg, I. (2007). The interface between borderline personality disorder and bipolar spectrum disorders. Comprehensive Psychiatry, 48, 145–154.
Paris, J., Silk, K.R., Gunderson, J., Links, P.S., and Zanarini, M. (2009). The case for retaining borderline personality disorder as a psychiatric diagnosis. Personality and Mental Health, 3(2), 96–100.
Pazzagli, A. and Monti, M.R. (2000). Dysphoria and aloneness in borderline personality disorder. Psychopathology, 33, 220–226.
Pepper, C.M., Klein, D.N., Anderson, R.L.et al. (1995). DSM-III-R axis II comorbidity in dysthymia and major depression. American Journal of Psychiatry, 152, 239–247.
Pfohl, B., Stangl, D., and Zimmerman, M. (1984). The implications of DSM-III personality disorders for patients with major depression. Journal of Affective Disorders, 7, 309–318.
Quitkin, F.M., Stewart, J.W., McGrath, P.J.et al. (1993). Columbia atypical depression: A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. The British Journal of Psychiatry, 163 Suppl 21, 30–34.
Ressler, K.J. and Mayberg, H.S. (2007). Targeting abnormal neural circuits in mood and anxiety disorders: From the laboratory to the clinic. Nature Neuroscience, 10, 1116–1124.
Rinne, T., van den Brink, W., Wouters, L., and van Dyck, R. (2002). SSRI treatment of borderline personality disorder: A randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. American Journal of Psychiatry, 159, 2048–2054.
Riso, L.P., Klein, D.N., and Anderson, R.L. (2000). A families study of outpatients with borderline personality disorder and no history of mood disorder. Journal of Personality Disorders, 14, 208–217.
Rogers, J.H., Widiger, T.A., and Krupp, A. (1995). Aspects of depression associated with borderline personality disorder. American Journal of Psychiatry, 152, 268–270.
Runeson, B. and Beskow, J. (1991). Borderline personality disorder in young Swedish suicides. Journal of Nervous and Mental Disease, 179, 153–156.
Schmahl, C.G., Elzinga, B.M., Vermetten, E.et al. (2003a). Neural correlates of memories of abandonment in women with and without borderline personality disorder. Biological Psychiatry, 54, 142–151.
Schmahl, C.G., Vermetten, E., Elzinga, B.M., and Bremner, D.J. (2003b). Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder. Psychiatry Research, 122, 193–198.
Siever, L.J., Buchsbaum, M.S., New, A.S.et al. (1999). d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology, 20, 413–423.
Silbersweig, D., Clarkin, J.F., Goldstein, M.et al. (2007). Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. American Journal of Psychiatry, 164, 1832–1841.
Silk, K.R. (2011). The process of managing medications in patients with borderline personality disorder. Journal of Psychiatric Practice, 17, 311–319.
Skodol, A.E., Grilo, C.M., Keyes, K.M.et al. (2011). Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. American Journal of Psychiatry, 168, 257–264.
Smith, D.J., Muir, W.J., and Blacwood, D.H.R. (2004). Is borderline personality disorder part of the bipolar spectrum? Harvard Review of Psychiatry, 12, 133–138.
Soloff, P. (2000). Psychopharmacology of borderline personality disorder. Psychiatric Clinics of North America, 23, 169–192.
Soloff, P.H., LynchK.G., Kelly, T.M., Malone, K.M., and Mann, J.J. (2000a). Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: A comparative study. American Journal of Psychiatry, 157, 601–608.
Soloff, P.H., Meltzer, C.C., Greer, P.J., Constantine, D., and Kelly, T.M. (2000b). A fenfluramine-activated FDG-PET study of borderline personality disorder. Biological Psychiatry, 47, 540–547.
Stanley, B. and Wilson, S.T. (2006). Heightened subjective experience of depression in borderline personality disorder. Journal of Personality Disorders, 20, 307–318.
Stanley, B. and Siever, L.J. (2010). The interpersonal dimension of borderline personality disorder: Toward a neuropeptide model. American Journal of Psychiatry, 167, 24–39.
Stanley, B., Sher, L., Wilson, S.et al. (2010). Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. Journal of Affective Disorders, 124, 134–140.
Stiglmayr, C.E., Grathwol, T., Linehan, M.M.et al. (2005). Aversive tension in patients with borderline personality disorder: a computer-based controlled field study. Acta Psychiatrica Scandinavica, 111, 372–379.
Swartz, H.A. (2005). Acute treatment outcomes in patients with bipolar I disorder and co-occurring borderline personality disorder receiving medication and psychotherapy. Bipolar Disorders, 7, 192–197.
van Elst, L.T., Thiel, T., Hesslinger, B.et al. (2001). Subtle prefrontal neuropathology in a pilot magnetic resonance spectroscopy study in patients with borderline personality disorder. Journal of Neuropsychiatry and Clinical Neuroscience, 13, 511–514.
van Elst, L.T., Hesslinger, B., Thiel, T.et al. (2003). Frontolimbic brain abnormalities in patients with borderline personality disorder: A volumetric magnetic resonance imaging study. Biological Psychiatry, 54, 163–171.
Westen, D., Moses, M.J., Silk, K.R.et al. (1992). Quality of depressive experience in borderline personality disorder and major depression: When depression is not just depression. Journal of Personality Disorders, 6, 382–393.
Wilson, S.T., Stanley, B., Oquendo, M.A.et al. (2007). Comparing impulsiveness, hostility, and depression in borderline personality disorder and bipolar II disorder. Journal of Clinical Psychiatry, 68, 1533.
Wingenfeld, K., Spitzer, C., Rullkvatter, N., and Lowe, B. (2009). Borderline personality disorder: Hypothalamus pituitary adrenal axis and findings from neuroimaging studies. Psychoneuroendocrinology, 35, 154–170.
Yen, S., Shea, M.T., Sanislow, C.A.et al. (2004). Borderline personality disorder criteria associated with prospectively observed suicidal behavior. American Journal of Psychiatry, 161, 1296–1298.
Zanarini, M.C. and Frankenburg, F.R. (2007). The essential nature of borderline psychopathology. Journal of Personality Disorders, 21, 518–535.
Zanarini, M.C., Frankenburg, F.R., Hennen, J., and Silk, K.R. (2003). The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. American Journal of Psychiatry, 160, 274–283.
Zanarini, M.C., Frankenburg, F.R., DeLuca, C.J.et al. (1998). The pain of being borderline: Dysphoric states specific to borderline personality disorder. Harvard Reviews of Psychiatry, 6, 201–207.
Zanarini, M.C., Frankenburg, F.R., Hennen, J.et al. (2004). Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. American Journal of Psychiatry, 161, 2108–2114.
Zimmerman, M. and Mattia, J.I. (1999). Axis I diagnostic comorbidity and borderline personality disorder. Comprehensive Psychiatry, 40, 245–252.
Zimmerman, M., Galione, J.N., Chelminski, I.et al. (2010). Sustained unemployment in psychiatric outpatients with bipolar disorder: Frequency and association with demographic variables and comorbid disorders. Bipolar Disorders, 12, 720–726.